1. Aghajanian, G. K., Bunney, B. S.: Pre- and postsynaptic feedback mechanisms in central dopaminergic neurons. In: Frontiers in Neurology and Neuroscience Research (Seeman, P., Brown, G. M., eds.), pp. 4?11. Toronto: The University of Toronto Press. 1974.
2. Ahlenius, S., Engel, J.: Behavioral effects of haloperidol after tyrosine hydroxylase inhibition. European J. Pharmacol.15, 187?192 (1971).
3. Andén, N.-E.: The interaction of neuroleptic drugs with striatal and limbic dopaminergic mechanisms. In: Antipsychotic drugs, pharmacodynamics and pharmacokinetics (Sedvall, G., Uvnäs, B., Zotterman, Y., eds.), pp. 217?225. Oxford: Pergamon Press. 1975.
4. Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. European J. Pharmacol.11, 303?314 (1970).
5. Andén, N.-E., Roos, B.-E., Werdinius, B.: Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum. Life Sci.3, 149?158 (1964).